title: C-terminal cleavage of human Foxp3 at a proprotein convertase motif abrogates its suppressive function.
abstract: Foxp3 plays a critical role in the development and function of regulatory T cells (Tregs). Differences in translational and post-translational processing of murine and human Foxp3 have been recently reported. Human Foxp3 exists as four isoforms generated by alternative splicing. Mouse Foxp3 only exists as one isoform, but can be proteolytically cleaved by N-terminal and/or C-terminal proprotein convertase subtilisin/kexins (PCSKs). Here, we show by transcriptome analysis that the proprotein convertases PCSK7, PCSK5 and Furin are present in human CD4(+) T cells with different expression patterns. Notably, after in vitro activation, only PCSK7 and Furin are expressed in Tregs and T effector cells (Teffs), with overexpression of PCSK7 in Tregs compared to Teffs. Human Foxp3 protein displays specific motifs that can be potentially cleaved by convertases. Consequently, we transduced human CD4(+) cells with Foxp3-expressing lentiviral vectors and assessed the generation of proteolytically cleaved Foxp3 forms by Western blot. Three different Foxp3 forms were detected, indicating that human Foxp3 can also be subjected to proteolytic cleavage at the N-terminal and C-terminal ends. These results prompted us to assess the suppressive activity associated with each forms. We observed that full length and N-cleaved Foxp3-transduced CD4(+) T cells similarly suppressed the in vitro proliferation of Teffs. However, the C-cleaved or N&C-cleaved Foxp3 forms afforded almost no suppressive function, indicating a crucial role of the human Foxp3 C-terminal region in Tregs suppressive activity, in marked contrast with the report of a superior suppressive activity for the C-cleaved murine Foxp3 compared to the full length.
authors: Immunology-Immunopathology-Immunotherapy (I3), Sorbonne Universités, UPMC Univ Paris 06, UMR 7211, UMRS 959, Paris, France; Immunology-Immunopathology-Immunotherapy (I3), CNRS, UMR 7211 and FRE 3632, Paris, France; Immunology-Immunopathology-Immunotherapy (I3), INSERM, UMRS 959, Paris, France.
authors: R
authors: R
authors: Elhage
authors: M
authors: M
authors: Cheraï
authors: B
authors: B
authors: Levacher
authors: G
authors: G
authors: Darrasse-Jeze
authors: C
authors: C
authors: Baillou
authors: X
authors: X
authors: Zhao
authors: A-M
authors: AM
authors: Khatib
authors: E
authors: E
authors: Piaggio
authors: D
authors: D
authors: Klatzmann
mesh_terms: D000328:Adult; D015496:CD4-Positive T-Lymphocytes / Q000276:immunology*; D049109:Cell Proliferation; D005434:Flow Cytometry; D051858:Forkhead Transcription Factors / Q000276:immunology*; D020869:Gene Expression Profiling; D006801:Humans; D008875:Middle Aged; D043484:Proprotein Convertases / Q000276:immunology*; D020033:Protein Isoforms / Q000276:immunology; D013381:Subtilisins / Q000276:immunology*; D050378:T-Lymphocytes, Regulatory / Q000276:immunology*; D014162:Transfection; D055815:Young Adult
chemical_list: C418974:FOXP3 protein, human; D051858:Forkhead Transcription Factors; D020033:Protein Isoforms; C099101:PCSK7 protein, human; D043484:Proprotein Convertases; D013381:Subtilisins